###begin article-title 0
###xml 101 106 97 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 107 111 <span type="species:ncbi:10090">Mice</span>
Leptin Administration Favors Muscle Mass Accretion by Decreasing FoxO3a and Increasing PGC-1alpha in ob/ob Mice
###end article-title 0
###begin p 1
Conceived and designed the experiments: NS JGA GF. Performed the experiments: NS AR VC SB BR. Analyzed the data: NS AR VC SB BR JGA GF. Contributed reagents/materials/analysis tools: JGA GF. Wrote the paper: NS AR VC JGA GF.
###end p 1
###begin p 2
###xml 92 97 92 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 338 343 338 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 440 441 440 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 581 582 581 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 701 702 701 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 743 744 743 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 780 781 780 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 948 949 936 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1052 1053 1040 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1173 1174 1161 1162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1300 1305 1288 1293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 344 348 <span type="species:ncbi:10090">mice</span>
###xml 1306 1310 <span type="species:ncbi:10090">mice</span>
Absence of leptin has been associated with reduced skeletal muscle mass in leptin-deficient ob/ob mice. The aim of our study was to examine the effect of leptin on the catabolic and anabolic pathways regulating muscle mass. Gastrocnemius, extensor digitorum longus and soleus muscle mass as well as fiber size were significantly lower in ob/ob mice compared to wild type littermates, being significantly increased by leptin administration (P<0.001). This effect was associated with an inactivation of the muscle atrophy-related transcription factor forkhead box class O3 (FoxO3a) (P<0.05), and with a decrease in the protein expression levels of the E3 ubiquitin-ligases muscle atrophy F-box (MAFbx) (P<0.05) and muscle RING finger 1 (MuRF1) (P<0.05). Moreover, leptin increased (P<0.01) protein expression levels of peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha), a regulator of muscle fiber type, and decreased (P<0.05) myostatin protein, a negative regulator of muscle growth. Leptin administration also activated (P<0.01) the regulators of cell cycle progression proliferating cell nuclear antigen (PCNA) and cyclin D1, and increased (P<0.01) myofibrillar protein troponin T. The present study provides evidence that leptin treatment may increase muscle mass of ob/ob mice by inhibiting myofibrillar protein degradation as well as enhancing muscle cell proliferation.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 27 29 27 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob</italic>
###xml 152 155 152 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Sahu1">[1]</xref>
###xml 348 351 348 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Margetic1">[2]</xref>
###xml 353 356 353 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Frhbeck1">[3]</xref>
###xml 422 425 422 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Frhbeck1">[3]</xref>
###xml 427 430 427 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Ceddia1">[4]</xref>
###xml 484 489 484 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 534 537 534 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Trostler1">[5]</xref>
###xml 490 494 <span type="species:ncbi:10090">mice</span>
Leptin, the product of the ob gene, is a hormone that acts as an afferent signal in a negative-feedback loop regulating the size of adipose tissue mass [1]. In addition to its function as a satiety factor, leptin regulates several physiological processes, such as glucose and lipid metabolism, immunity, reproduction and blood pressure homeostasis [2], [3]. Skeletal muscle also constitutes an important target for leptin [3], [4]. Several studies have reported that leptin-deficient ob/ob mice display a reduced skeletal muscle mass [5] compared with their lean littermates. However, the mechanisms whereby leptin regulates muscle growth are poorly understood.
###end p 4
###begin p 5
###xml 330 333 330 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Eley1">[6]</xref>
###xml 789 792 789 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Pickart1">[7]</xref>
###xml 935 938 935 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Bodine1">[8]</xref>
###xml 940 943 940 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Gomes1">[9]</xref>
###xml 1069 1073 1069 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Accili1">[10]</xref>
###xml 1227 1231 1227 1231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Sandri1">[11]</xref>
###xml 1232 1236 1232 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Waddell1">[13]</xref>
###xml 1286 1290 1286 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Kamei1">[14]</xref>
###xml 1342 1346 1342 1346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Rathbone1">[15]</xref>
###xml 1666 1670 1666 1670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Stitt1">[16]</xref>
###xml 1780 1784 1780 1784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Hu1">[17]</xref>
###xml 1786 1790 1786 1790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Moylan1">[18]</xref>
###xml 2056 2060 2048 2052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Sandri2">[19]</xref>
Skeletal muscle mass and composition are critical for exercise, energy expenditure and glucose metabolism. Although the underlying mechanisms involved in the development of muscle atrophy are poorly understood, an imbalance between protein breakdown and synthesis, in favour of the former, plays an important role in this process [6]. The ubiquitin-proteasome system (UPS) is critical for the specific degradation of cellular proteins, being the main proteolytic system for protein breakdown in muscular atrophy. UPS induces the expression of the ubiquitin ligases E3 muscle atrophy F-box (MAFbx, also known as atrogin-1) and muscle RING finger-1 (MuRF1). These ubiquitin ligases target proteins with a ubiquitin chain to be subsequently degraded within the proteasome complex to peptides [7]. Both MAFbx and MuRF1 have been shown to be up-regulated in different models of atrophy, conferring them the status of muscle atrophy markers [8], [9]. Another key mediator in protein breakdown during atrophy is the forkhead box class O (FoxO) family of transcription factors [10]. In this sense, FoxO1 and FoxO3a, which are highly expressed in skeletal muscle, induce muscle mass loss by increasing the expression of MAFbx and MuRF1 [11]-[13], by inhibiting muscle growth and differentiation [14] and by impairing the progression of the cell cycle [15]. On the other hand, the enhancement of overall protein breakdown is blocked by the Akt signaling pathway. In its phosphorylated active form, Akt triggers the phosphorylation/inactivation of FoxO transcription factors, sequestering them to the cytosol, where they are unable to activate transcription of MAFbx and MuRF1 [16]. Nonetheless, under certain conditions, the regulation of Akt and FoxO seems to be independent of each other [17], [18]. Recently, it has been reported that peroxisome proliferator-activated receptor coactivator 1alpha (PGC-1alpha) also constitutes an important mediator of muscle mass down-regulating the expression levels and activity of FoxO3a and, hence, inhibiting muscle atrophy [19].
###end p 5
###begin p 6
###xml 79 82 79 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Eley1">[6]</xref>
###xml 169 174 169 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 180 184 180 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Muzzin1">[20]</xref>
###xml 309 314 309 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 547 552 547 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
###xml 553 557 <span type="species:ncbi:10090">mice</span>
Obesity and insulin resistance exhibit a derangement in muscle mass regulation [6]. In this context, leptin has been shown to revert the obese and diabetic phenotype of ob/ob mice [20]. Thus, the aim of our study was to examine the catabolic and anabolic pathways involved in the regulation of muscle mass of ob/ob mice, and whether leptin administration normalizes the reduced skeletal muscle mass of leptin-deficient animals through FoxO-dependent mechanisms. Data of our study provide evidence that leptin treatment may increase muscle mass of ob/ob mice by inhibiting muscular atrophy markers as well as enhancing positive regulators of muscle cell proliferation.
###end p 6
###begin title 7
Results
###end title 7
###begin title 8
Leptin Administration Increases Muscle Mass
###end title 8
###begin p 9
###xml 68 73 68 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 143 148 143 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 383 388 383 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 568 573 568 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 673 678 673 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 798 807 798 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006808.s005">Figure S1</xref>
###xml 859 864 859 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 886 894 886 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006808.s001">Table S1</xref>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 149 153 <span type="species:ncbi:10090">mice</span>
###xml 389 393 <span type="species:ncbi:10090">mice</span>
###xml 574 578 <span type="species:ncbi:10090">mice</span>
###xml 756 760 <span type="species:ncbi:10090">mice</span>
###xml 865 869 <span type="species:ncbi:10090">mice</span>
As expected, undetectable serum leptin concentrations were found in ob/ob mice. Leptin administration increased leptin levels in wild type and ob/ob mice. Importantly, the determination of leptin was performed 20 hours after the last exogenous administration of the hormone and measured values were whitin the nanomolar range observed under physiological circumstances. In addition, ob/ob mice used in our study were obese, hyperinsulinemic, hyperglycemic and hyperlipidemic. Leptin treatment corrected the obese phenotype and improved glucose and lipid metabolism of ob/ob mice, independently of the inhibitory effect of leptin on food intake, as compared to the pair-fed ob/ob group. Moreover, leptin also decreased body weight and fat mass of wild type mice independently of appetite reduction (Figure S1). The biochemical characteristics of wild type and ob/ob mice are reported in Table S1.
###end p 9
###begin p 10
###xml 36 37 36 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 80 81 80 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 108 109 108 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 153 158 153 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 181 190 181 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wild type</italic>
###xml 253 261 253 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006808-g001">Figure 1</xref>
###xml 332 333 332 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 344 349 344 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 351 352 351 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 444 445 444 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 466 467 466 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 547 552 547 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 559 560 559 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 681 682 681 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 758 759 758 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 854 859 854 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 891 892 891 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 964 965 964 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1064 1065 1064 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1231 1236 1231 1236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 159 163 <span type="species:ncbi:10090">mice</span>
###xml 359 363 <span type="species:ncbi:10090">mice</span>
###xml 553 557 <span type="species:ncbi:10090">mice</span>
###xml 643 647 <span type="species:ncbi:10090">mice</span>
###xml 752 756 <span type="species:ncbi:10090">mice</span>
###xml 1058 1062 <span type="species:ncbi:10090">mice</span>
###xml 1126 1130 <span type="species:ncbi:10090">mice</span>
###xml 1237 1241 <span type="species:ncbi:10090">mice</span>
The weights of gastrocnemius (GAS) (P<0.0001), extensor digitorum longus (EDL) (P<0.0001) and soleus (SOL) (P<0.001) muscles were significantly lower in ob/ob mice as compared with wild type, showing a strong effect of leptin deficiency on muscle mass (Figure 1). In addition, pair-feeding decreased the weight of GAS in wild type (P<0.05) and ob/ob (P<0.01) mice. Leptin treatment significantly increased GAS and EDL mass compared to control (P<0.05) and pair-fed (P<0.01) obese animals and prevented the SOL mass loss induced by pair-feeding in ob/ob mice (P<0.05). Leptin administration also increased the weight of GAS muscle in wild type mice as compared to pair-fed animals (P<0.01). Curiously, the hormone reduced the weight of EDL in wild type mice (P<0.05). The cross-sectional area (CSA) of GAS, EDL and SOL muscle fibers was also decreased in ob/ob compared to wild type animals (P<0.0001), a condition that was completely reverted by leptin treatment (P<0.0001). Surprisingly, pair-feeding increased CSA of EDL and SOL muscle fibers in wild type mice (P<0.0001), which was not observed in leptin-treated wild type mice. Therefore, our data show that leptin administration increases muscle mass and muscle fiber size of ob/ob mice.
###end p 10
###begin title 11
###xml 54 59 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 60 64 <span type="species:ncbi:10090">Mice</span>
Leptin Increases Muscle Mass and Muscle Fiber Size of ob/ob Mice.
###end title 11
###begin p 12
###xml 162 167 162 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 196 197 196 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 206 207 206 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 220 221 220 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 367 372 367 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 433 434 433 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 448 449 448 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 570 575 570 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 168 172 <span type="species:ncbi:10090">mice</span>
###xml 373 377 <span type="species:ncbi:10090">mice</span>
###xml 418 422 <span type="species:ncbi:10090">mice</span>
###xml 576 580 <span type="species:ncbi:10090">mice</span>
(A) Gastrocnemius (GAS), extensor digitorum longus (EDL) and soleus (SOL) muscle weights of PBS (open), pair-fed (gray) and leptin-treated (closed) wild type and ob/ob mice (n = 9-10 per group). *P<0.05, **P<0.01 and ***P<0.001. (B) Cross-sectional area (CSA) of GAS, EDL and SOL muscle fibers of PBS (open), pair-fed (gray) and leptin-treated (closed) wild type and ob/ob mice (approximately 100 fibers/muscle from 3 mice/group). **P<0.001 and ***P<0.0001. (C) Representative histological sections of hematoxylin-eosin-stained GAS, EDL and SOL muscles of wild type and ob/ob mice. Scale bars = 200 microm. Results are presented as mean+/-SEM. G: genotype, T: treatment.
###end p 12
###begin title 13
Gene Expression Profiles Reveal Significant Changes in Skeletal Muscle after Leptin Treatment
###end title 13
###begin p 14
###xml 137 142 137 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 318 323 318 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 343 348 343 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 366 375 366 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006808.s006">Figure S2</xref>
###xml 492 500 492 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs ob/ob</italic>
###xml 593 601 593 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob vs</italic>
###xml 617 622 617 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 755 763 755 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob vs</italic>
###xml 779 784 779 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 1099 1108 1099 1108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006808.s002">Tables S2</xref>
###xml 1113 1115 1113 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006808.s003">S3</xref>
###xml 1276 1281 1276 1281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 1288 1337 1288 1337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Igf1, Igfbp5, Notch3, Ccnd1, Clk4, Cited4, Cdc14a</italic>
###xml 1370 1374 1370 1374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eya1</italic>
###xml 1376 1380 1376 1380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mkl1</italic>
###xml 1382 1385 1382 1385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Srf</italic>
###xml 1451 1461 1451 1461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cdkn1a/p21</italic>
###xml 1473 1477 1473 1477 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 1464 1477 1464 1477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dkn1b/p27<sup>Kip1</sup></italic>
###xml 1481 1485 1481 1485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rbl2</italic>
###xml 1535 1540 1535 1540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 1660 1692 1660 1692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fbxo32/MAFbx, Need4, Ube2h, Ub1x</italic>
###xml 1706 1731 1706 1731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Acin1, Amid, Dffa, Bclaf1</italic>
###xml 1748 1769 1748 1769 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lysmd3, Becn1, Atg121</italic>
###xml 1821 1831 1821 1831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apip, Bcl2</italic>
###xml 1834 1842 1834 1842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006808-t001">Tables 1</xref>
###xml 1847 1849 1847 1849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006808.s002">S2</xref>
###xml 1961 1973 1961 1973 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eif4e, Eefe1</italic>
###xml 2045 2056 2045 2056 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gsk3b, Pten</italic>
###xml 2154 2164 2154 2164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myh1/Mhc2x</italic>
###xml 2166 2176 2166 2176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myh2/Mhc2a</italic>
###xml 2178 2187 2178 2187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myh7/Mhc1</italic>
###xml 2189 2199 2189 2199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myl3, Myl4</italic>
###xml 2212 2217 2212 2217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tnni1</italic>
###xml 2219 2224 2219 2224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tnnt1</italic>
###xml 2226 2231 2226 2231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tnnc1</italic>
###xml 2247 2251 2247 2251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tpm3</italic>
###xml 2263 2266 2263 2266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Neb</italic>
###xml 2279 2282 2279 2282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ttn</italic>
###xml 2323 2328 2323 2328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 2335 2343 2335 2343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006808-t001">Tables 1</xref>
###xml 2348 2350 2348 2350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006808.s002">S2</xref>
###xml 2450 2483 2450 2483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trim63/MuRF1, Fbxo32/MAFbx, Foxo1</italic>
###xml 2500 2509 2500 2509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gabarap11</italic>
###xml 2538 2543 2538 2543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 2550 2558 2550 2558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006808.s003">Table S3</xref>
###xml 2861 2870 2861 2870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006808.s007">Figure S3</xref>
###xml 143 147 <span type="species:ncbi:10090">mice</span>
###xml 349 353 <span type="species:ncbi:10090">mice</span>
###xml 623 627 <span type="species:ncbi:10090">mice</span>
###xml 1282 1286 <span type="species:ncbi:10090">mice</span>
###xml 1541 1545 <span type="species:ncbi:10090">mice</span>
###xml 2329 2333 <span type="species:ncbi:10090">mice</span>
###xml 2544 2548 <span type="species:ncbi:10090">mice</span>
To investigate the effect of leptin on the catabolic and anabolic pathways involved in the regulation of the GAS muscle of wild type and ob/ob mice, their differential gene expression profiles were analyzed by microarray analysis. The hierarchical clustering of the gene expression profile in GAS muscle of wild type, ob/ob and leptin-treated ob/ob mice is shown in Figure S2. Microarray data showed 1,127 genes with differential expression (1.5-fold change) for leptin deficiency (wild type vs ob/ob; 51.5% up-regulated and 48.5% down-regulated genes), 1,546 genes for leptin administration (ob/ob vs leptin-treated ob/ob mice; 33.1% up-regulated and 66.9% down-regulated genes), and 1,960 for appetite inhibiting-independent effects of leptin (pair-fed ob/ob vs leptin-treated ob/ob group; 50.2% up-regulated and 49.8 down-regulated genes). The set of genes with altered expression levels induced by leptin deficiency and administration represents a broad spectrum of biological processes involved in muscle growth and atrophy, such as cell cycle progression, ubiquitin-proteolysis and apoptosis (Tables S2 and S3 in Supporting Information). Our study shows an up-regulation of positive regulators of muscle growth and cell cycle progression in GAS muscle of leptin-treated ob/ob mice (Igf1, Igfbp5, Notch3, Ccnd1, Clk4, Cited4, Cdc14a), and myoblast differentiation (Eya1, Mkl1, Srf), whereas negative regulators of cell cycle progression, such as Cdkn1a/p21, Cdkn1b/p27Kip1 or Rbl2, were down-regulated by leptin administration in ob/ob mice. Moreover, leptin treatment down-regulated the expression levels of positive regulators of ubiquitin proteolysis (Fbxo32/MAFbx, Need4, Ube2h, Ub1x), apoptosis (Acin1, Amid, Dffa, Bclaf1) and autophagy (Lysmd3, Becn1, Atg121) and up-regulated inhibitory factors of apoptosis (Apip, Bcl2) (Tables 1 and S2). Leptin administration also increased the gene expression levels of positive regulators of protein synthesis (Eif4e, Eefe1) and decreased the mRNA expression of inhibitors of protein synthesis (Gsk3b, Pten). Increased gene expression levels codifying for the contractile and sarcomeric proteins myosin (Myh1/Mhc2x, Myh2/Mhc2a, Myh7/Mhc1, Myl3, Myl4), troponin (Tnni1, Tnnt1, Tnnc1), tropomyosin (Tpm3), nebulin (Neb) and titin (Ttn) were normalized by leptin treatment in ob/ob mice (Tables 1 and S2). Furthermore, leptin prevented the up-regulation of positive regulators of ubiquitin proteolysis (Trim63/MuRF1, Fbxo32/MAFbx, Foxo1) and autophagy (Gabarap11) induced by pair-feeding in ob/ob mice (Table S3). Microarray data evidenced that leptin is an important regulator of the expression of genes involved in muscle growth and muscle atrophy. To confirm the microarray data, the mRNA expression of a number of representative transcripts involved in muscle growth and atrophy was analyzed by Real-Time PCR (Figure S3).
###end p 14
###begin title 15
Selected Genes Regulated by Leptin in Gastrocnemius Muscle.
###end title 15
###begin p 16
###xml 21 29 21 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob vs</italic>
###xml 45 50 45 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 104 112 104 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006808.s002">Table S2</xref>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
Fold changes between ob/ob vs leptin-treated ob/ob mice of selected differentially expressed genes from Table S2.
###end p 16
###begin title 17
Leptin Administration Protects from Muscular Atrophy
###end title 17
###begin p 18
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxo1</italic>
###xml 53 59 53 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxo3a</italic>
###xml 110 115 110 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 227 236 227 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006808.s007">Figure S3</xref>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
No differences in the transcript levels of Foxo1 and Foxo3a in GAS muscle were detected between wild type and ob/ob mice, but a tendency towards a down-regulation of both transcription factors was found after leptin treatment (Figure S3).
###end p 18
###begin p 19
###xml 76 77 76 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 90 95 90 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 191 192 191 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 219 224 219 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 231 240 231 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006808-g002">Figure 2A</xref>
###xml 421 426 421 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 456 457 456 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 488 489 488 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 574 583 574 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006808-g002">Figure 2B</xref>
###xml 696 701 696 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 708 709 708 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 720 729 720 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006808-g002">Figure 2C</xref>
###xml 787 788 787 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 799 809 799 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pgc-1&#945;</italic>
###xml 839 844 835 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 851 860 847 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006808.s007">Figure S3</xref>
###xml 969 974 961 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 1008 1009 1000 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1099 1100 1087 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1171 1176 1159 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 1183 1192 1171 1180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006808-g002">Figure 2D</xref>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
###xml 225 229 <span type="species:ncbi:10090">mice</span>
###xml 427 431 <span type="species:ncbi:10090">mice</span>
###xml 702 706 <span type="species:ncbi:10090">mice</span>
###xml 845 849 <span type="species:ncbi:10090">mice</span>
###xml 975 979 <span type="species:ncbi:10090">mice</span>
###xml 1002 1006 <span type="species:ncbi:10090">mice</span>
###xml 1177 1181 <span type="species:ncbi:10090">mice</span>
Nonetheless, at the protein level, the active form of FoxO3a was increased (P = 0.012) in ob/ob mice, with the phosphorylated-FoxO3a (inactive form) being increased by leptin administration (P = 0.023) in wild type and ob/ob mice (Figure 2A). Thus, since the activity of FoxO3a is inhibited by phosphorylation, data show that leptin reduces the functional form of this transcription factor in GAS muscle of wild type and ob/ob mice. No effect of genotype (P = 0.833) or leptin treatment (P = 0.279) was observed on the activity of Akt in GAS muscle of experimental animals (Figure 2B). On the contrary, the activity of the AMP-activated protein kinase (AMPK) was increased by leptin treatment in ob/ob mice (P = 0.033) (Figure 2C). Gene expression studies showed a significant decrease (P<0.001) in Pgc-1alpha mRNA levels in GAS muscle of ob/ob mice (Figure S3). The effect of leptin deficiency on PGC-1alpha protein expression showed a similar pattern, being lower in ob/ob mice compared to wild type mice (P = 0.010). However, protein expression levels of PGC-1alpha were significantly increased (P = 0.005) by leptin administration in skeletal muscle of wild type and ob/ob mice (Figure 2D).
###end p 19
###begin title 20
Leptin Decreases FoxO3a Activity and Increases PGC-1alpha Protein in Gastrocnemius Muscle.
###end title 20
###begin p 21
###xml 199 204 199 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 490 495 487 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 763 768 760 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 962 967 955 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 205 209 <span type="species:ncbi:10090">mice</span>
###xml 496 500 <span type="species:ncbi:10090">mice</span>
###xml 769 773 <span type="species:ncbi:10090">mice</span>
###xml 968 972 <span type="species:ncbi:10090">mice</span>
(A) Representative Western blot analyses of forkhead box class O (FoxO3a) and phospho-FoxO3a proteins of gastrocnemius muscle of PBS (open), pair-fed (gray) and leptin-treated (closed) wild type and ob/ob mice are shown. beta-actin was used as a loading control (n = 8 per group). (B) Representative Western blot analyses of Akt activity evidenced by phosphorylated-Akt and Akt proteins ratio of gastrocnemius muscle of PBS (open), pair-fed (gray) and leptin-treated (closed) wild type and ob/ob mice (n = 8 per group). (C) Representative Western blot analyses of AMP-activated protein kinase (AMPK) activity evidenced by phosphorylated-AMPK and AMPK proteins ratio of gastrocnemius muscle of PBS (open), pair-fed (gray) and leptin-treated (closed) wild type and ob/ob mice are shown (n = 5 per group). (D) Representative Western blot analyses of AMP- (PGC-1alpha) of gastrocnemius muscle of PBS (open), pair-fed (gray) and leptin-treated (closed) wild type and ob/ob mice are shown. beta-actin was used as a loading control (n = 8 per group). Data are expressed as mean+/-SEM. G: genotype, T: treatment.
###end p 21
###begin p 22
###xml 83 84 83 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 126 131 126 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 221 230 221 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006808.s007">Figure S3</xref>
###xml 235 243 235 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006808.s003">Table S3</xref>
###xml 276 277 276 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 298 299 298 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 377 382 377 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 389 398 389 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006808-g003">Figure 3A</xref>
###xml 681 686 681 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 817 822 817 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 830 839 830 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006808-g003">Figure 3B</xref>
###xml 1013 1018 1013 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 132 136 <span type="species:ncbi:10090">mice</span>
###xml 383 387 <span type="species:ncbi:10090">mice</span>
###xml 687 691 <span type="species:ncbi:10090">mice</span>
###xml 717 721 <span type="species:ncbi:10090">mice</span>
###xml 1019 1023 <span type="species:ncbi:10090">mice</span>
Leptin treatment decreased the mRNA expression levels of the atrophy marker MAFbx (P = 0.006) and tended to decrease MuRF1 in ob/ob mice, although no significant differences were found for the global effect of treatment (Figure S3 and Table S3). The protein content of MAFbx (P = 0.014) and MuRF1 (P = 0.021) was also reduced by leptin treatment in GAS muscle of wild type and ob/ob mice (Figure 3A). Since MAFbx and MuRF1 proteins have been associated with myofibrillar protein degradation, their tissue distribution was analyzed by immunohistochemical analysis. Fiber sections of GAS muscle showed higher sarcolemmal, cytosolic and nuclear immunoreactivity of MAFbx and MuRF1 in ob/ob mice as compared to wild type mice and, analogously to what happened with the protein content, were reduced in the leptin-treated ob/ob group (Figure 3B). Taken together, these results suggest that leptin administration decreases protein expression levels of the atrophy markers MAFbx and MuRFa in GAS muscle of wild type and ob/ob mice.
###end p 22
###begin title 23
###xml 93 98 93 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 99 103 <span type="species:ncbi:10090">Mice</span>
Leptin Decreases MAFbx and MuRF1 Protein Expression in Gastrocnemius Muscle of Wild Type and ob/ob Mice.
###end title 23
###begin p 24
###xml 212 217 212 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 295 296 292 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 218 222 <span type="species:ncbi:10090">mice</span>
(A) Representative Western blot analyses of muscle atrophy F box (MAFbx) and muscle RING finger 1 (MuRF1) proteins of gastrocnemius muscle of PBS (open), pair-fed (gray) and leptin-treated (closed) wild type and ob/ob mice are shown. beta-actin was used as a loading control (n = 8 per group). *P<0.05. (B) Immunostaining for MAFbx and MuRF1 proteins was assessed by optic microscopy. Representative images are shown for gastrocnemius muscle. Scale bars = 50 microm. Data are presented as mean+/-SEM. G: genotype, T: treatment.
###end p 24
###begin title 25
Leptin Treatment Enhances Skeletal Muscle Growth
###end title 25
###begin p 26
###xml 62 67 62 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 152 160 152 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006808.s002">Table S2</xref>
###xml 347 351 344 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-McPherron1">[21]</xref>
###xml 497 502 494 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 569 574 566 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 576 577 573 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 600 605 597 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 612 613 609 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 624 633 621 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006808-g004">Figure 4A</xref>
###xml 685 690 682 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
###xml 428 432 <span type="species:ncbi:10090">mice</span>
###xml 503 507 <span type="species:ncbi:10090">mice</span>
###xml 606 610 <span type="species:ncbi:10090">mice</span>
###xml 691 695 <span type="species:ncbi:10090">mice</span>
DNA microarray screening showed that leptin administration in ob/ob mice up-regulates genes involved in muscle growth and cell cycle in the GAS muscle (Table S2). We examined the effect of leptin on the protein expression of myostatin, a member of the transforming growth factor TGFbeta family, which acts as a negative regulator of muscle growth [21]. The mature form of myostatin (22 kDa) was almost undetectable in wild type mice. However, data showed a high protein expression of myostatin in ob/ob mice, which was reduced after leptin treatment as compared to the ob/ob (P = 0.026) and pair-fed ob/ob mice (P = 0.015) (Figure 4A), suggesting that leptin enhances muscle growth in ob/ob mice.
###end p 26
###begin title 27
Leptin Regulates Muscle Growth and Cell Cycle Factors.
###end title 27
###begin p 28
###xml 159 164 159 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 314 315 311 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 471 475 468 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 583 588 580 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 666 667 660 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 676 677 670 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 690 691 684 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 165 169 <span type="species:ncbi:10090">mice</span>
###xml 589 593 <span type="species:ncbi:10090">mice</span>
(A) Representative Western blot analyses of myostatin protein of gastrocnemius muscle of PBS (open), pair-fed (gray) and leptin-treated (closed) wild type and ob/ob mice are shown. beta-actin was used as a loading control (n = 2-6 per group). The myostatin band was detected only in 2 samples of wild type groups.*P<0.05. (B) Representative Western blot analyses of proliferating cell nuclear antigen (PCNA), cyclin D1 and cyclin-dependent kinase inhibitor 1B (Cdkn1b/p27Kip1) proteins of gastrocnemius muscle of PBS (open), pair-fed (gray) and leptin-treated (closed) wild type and ob/ob mice are shown. beta-actin was used as a loading control (n = 8 per group). *P<0.05, **P<0.01 and ***P<0.001. Data are expressed as mean+/-SEM. G: genotype, T: treatment.
###end p 28
###begin p 29
###xml 320 324 320 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Rosenblatt1">[22]</xref>
###xml 326 330 326 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Adams1">[23]</xref>
###xml 566 570 566 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Rathbone1">[15]</xref>
###xml 576 581 576 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 656 657 656 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 720 724 720 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Johnson1">[24]</xref>
###xml 726 730 726 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Hawke1">[25]</xref>
###xml 761 762 761 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 783 792 783 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006808-g004">Figure 4B</xref>
###xml 869 874 869 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 900 905 900 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 907 908 907 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 969 974 969 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 981 982 981 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1081 1085 1081 1085 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 1087 1096 1087 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006808-g004">Figure 4B</xref>
###xml 1233 1237 1233 1237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Borriello1">[26]</xref>
###xml 1238 1242 1238 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Diehl1">[28]</xref>
###xml 1482 1491 1482 1491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006808-g005">Figure 5A</xref>
###xml 1743 1744 1743 1744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1755 1764 1755 1764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006808-g005">Figure 5B</xref>
###xml 1781 1782 1781 1782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1793 1802 1793 1802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006808-g005">Figure 5C</xref>
###xml 1821 1826 1821 1826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 1853 1858 1853 1858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 1905 1909 1905 1909 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 1911 1912 1911 1912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1976 1981 1976 1981 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 1983 1984 1983 1984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2007 2012 2007 2012 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 2014 2015 2014 2015 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2031 2040 2031 2040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006808-g005">Figure 5D</xref>
###xml 2139 2144 2139 2144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 582 586 <span type="species:ncbi:10090">mice</span>
###xml 975 979 <span type="species:ncbi:10090">mice</span>
###xml 1827 1831 <span type="species:ncbi:10090">mice</span>
###xml 1859 1863 <span type="species:ncbi:10090">mice</span>
###xml 2025 2029 <span type="species:ncbi:10090">mice</span>
###xml 2145 2149 <span type="species:ncbi:10090">mice</span>
Myofibers are postmitotic muscle cells being unable to proliferate. Therefore, postnatal muscle growth depends on satellite cells, which are localized between the basal lamina and the plasmatic membrane of muscle fibers. Satellite cells are usually quiescent but are able to proliferate in response to mitogenic factors [22], [23]. The initiation of the cell cycle depends on the activity of the complexes of cyclin and cyclin-dependent kinases (CDK), while FoxO transcription factors inhibit the cell cycle progression of skeletal muscle by inducing CDK inhibitors [15]. The ob/ob mice showed an increase in the proliferating cell nuclear antigen (PCNA) (P = 0.010), a marker molecule for proliferating satellite cells [24], [25], and a decrease in cyclin D1 (P = 0.0001) proteins (Figure 4B). Interestingly, leptin treatment further increased PCNA as compared to the ob/ob (P = 0.021) and pair-fed ob/ob (P = 0.003) groups and tended to increase cyclin D1 protein in ob/ob mice (P = 0.055). No significant differences were found in the protein expression of the CDK inhibitor p27Kip1 (Figure 4B). Given that these regulators of the cell cycle are post-transcriptionally regulated by phosphorylation, being active within the nuclei [26]-[28], immunohistochemical analyses in sections of GAS muscle were performed to discriminate nuclear and cytosolic protein expression. In addition, we assessed immunostaining for the dystrophin protein, a marker molecule for plasmatic membrane (Figure 5A), to define positive PCNA nuclei and discriminate satellite cells from other cell types. In this sense, only nuclei between the basal lamina and the plasmatic membrane were counted. Leptin administration increased the nuclear immunostaining for PCNA (P = 0.002) (Figure 5B) and cyclin D1 (P = 0.005) (Figure 5C) in wild type and ob/ob mice. Moreover, nuclei of ob/ob mice showed an increased immunostaining of p27Kip1 (P = 0.002), which was reduced by leptin treatment as compared to ob/ob (P = 0.004) and pair-fed ob/ob (P = 0.015) mice (Figure 5D). These data provide evidence that leptin may enhance cell cycle progression in the GAS muscle of ob/ob mice.
###end p 29
###begin title 30
Leptin Enhances Muscle Cell Proliferation.
###end title 30
###begin p 31
###xml 99 104 99 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 352 357 348 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 407 408 399 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 620 625 612 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 748 752 736 740 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 876 881 864 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 930 931 914 915 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 943 944 927 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 105 109 <span type="species:ncbi:10090">mice</span>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
###xml 626 630 <span type="species:ncbi:10090">mice</span>
###xml 882 886 <span type="species:ncbi:10090">mice</span>
(A) Immunohistochemical staining for dystrophin and PCNA of gastrocnemious muscle of wild type and ob/ob mice (n = 3 per group). Scale bar = 50 microm. (B) Immunohistochemical staining and relative stained nuclei number for PCNA evaluated among 500 cells in gastrocnemius muscle of PBS (open), pair-fed (gray) and leptin-treated (closed) wild type and ob/ob mice (n = 3 per group). Scale bar = 50 microm. **P<0.01. (C) Immunohistochemical staining and relative stained nuclei number for cyclin D1 evaluated among 500 cells in gastrocnemius muscle of PBS (open), pair-fed (gray) and leptin-treated (closed) wild type and ob/ob mice (n = 3 per group). Scale bar = 50 microm. (D) Immunohistochemical staining and relative stained nuclei number for p27Kip1 evaluated among 500 cells in gastrocnemius muscle of PBS (open), pair-fed (gray) and leptin-treated (closed) wild type and ob/ob mice (n = 3 per group). Scale bar = 50 microm. *P<0.05 and **P<0.01. Data are expressed as mean+/-SEM. G: genotype, T: treatment.
###end p 31
###begin p 32
###xml 225 229 225 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Bruusgaard1">[29]</xref>
###xml 231 235 231 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-OConnor1">[30]</xref>
###xml 363 368 363 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 422 431 422 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006808.s007">Figure S3</xref>
###xml 436 444 436 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006808.s002">Table S2</xref>
###xml 573 581 573 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006808.s002">Table S2</xref>
###xml 655 664 655 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006808-g006">Figure 6A</xref>
###xml 803 808 803 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 815 824 815 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006808-g006">Figure 6B</xref>
###xml 883 892 883 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006808-g006">Figure 6C</xref>
###xml 369 373 <span type="species:ncbi:10090">mice</span>
###xml 809 813 <span type="species:ncbi:10090">mice</span>
The growth of skeletal muscle requires an increase in the number of myonuclei together with an increase in the synthesis of myofibrillar proteins to maintain a constant ratio between number of nuclei per fiber and fiber size [29], [30]. Gene expression analyses showed up-regulation of genes codifying for contractile and sarcomeric proteins in the GAS muscle of ob/ob mice, which was normalized by leptin administration (Figure S3 and Table S2). Moreover, although a positive regulation of genes involved in the synthesis of proteins was induced by leptin administration (Table S2), no effect on the protein expression of both isoforms of MHC was found (Figure 6A). However, the administration of the hormone significantly increased the slow and fast isoforms of TnT in the GAS muscle of wild type and ob/ob mice (Figure 6B). These data were also confirmed by immunohistochemistry (Figure 6C). Therefore, leptin increases the protein expression of slow and fast isoforms of the contractile protein TnT.
###end p 32
###begin title 33
Leptin Increases the Expression of Contractile Proteins in Skeletal Muscle.
###end title 33
###begin p 34
###xml 253 258 253 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 444 449 441 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 259 263 <span type="species:ncbi:10090">mice</span>
###xml 450 454 <span type="species:ncbi:10090">mice</span>
(A) Representative Western blot analyses of myosin heavy chain type I (MHC I), myosin heavy chain type II (MHC II), slow and fast troponin T (TnT) proteins of gastrocnemius muscle of PBS (open), pair-fed (gray) and leptin-treated (closed) wild type and ob/ob mice are shown. beta-actin was used as a loading control (n = 8 per group). (B) Immunohistochemical staining for slow and fast troponin T (TnT) of gastrocnemius muscle of wild type and ob/ob mice. Scale bars = 100 microm. Data are expressed as mean+/-SEM. G: genotype, T: treatment.
###end p 34
###begin title 35
Discussion
###end title 35
###begin p 36
###xml 162 165 162 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Eley1">[6]</xref>
###xml 167 171 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Frhbeck2">[31]</xref>
###xml 190 195 190 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 240 243 240 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Trostler1">[5]</xref>
###xml 245 249 245 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Bergen1">[32]</xref>
###xml 251 255 251 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Warmington1">[33]</xref>
###xml 300 304 300 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Trostler2">[34]</xref>
###xml 436 440 436 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Ramsay1">[35]</xref>
###xml 589 593 589 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Carbo1">[36]</xref>
###xml 779 784 779 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 196 200 <span type="species:ncbi:10090">mice</span>
###xml 584 588 <span type="species:ncbi:10116">rats</span>
###xml 785 789 <span type="species:ncbi:10090">mice</span>
Muscle loss is the result of a reduced protein synthesis and increased myofibrillar degradation in response to inactivity, food deprivation or catabolic diseases [6], [31]. Leptin-deficient ob/ob mice display a reduced skeletal muscle mass [5], [32], [33] and an increased muscle proteosome activity [34] compared to their lean counterparts. Moreover, leptin administration has been shown to inhibit protein breakdown in C2C12 myotubes [35]. However, other authors failed to observe any direct effect of leptin on the synthesis and degradation rates of proteins in skeletal muscle of rats [36], suggesting that leptin effects on muscle mass may be mediated by the release of a secondary growth factor. Our study provides evidence for a myogenic effect of leptin on wild type and ob/ob mice. The main findings reported herein are that: 1) leptin induces changes in the expression of transcription factors involved in muscle growth (reduced FoxO3a and increased PGC-1alpha); 2) leptin down-regulates the atrophy markers, MAFbx and MuRF1, as well as the negative regulator of muscle growth myostatin; and 3) leptin increases the positive cell cycle markers cyclin D1 and PCNA.
###end p 36
###begin title 37
Leptin Inhibits Muscular Atrophy
###end title 37
###begin p 38
###xml 249 253 249 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Greer1">[37]</xref>
###xml 254 258 254 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Nakashima1">[39]</xref>
###xml 337 342 337 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 474 479 474 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 695 699 695 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Sandri1">[11]</xref>
###xml 701 705 701 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Kamei1">[14]</xref>
###xml 718 725 718 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 730 738 730 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 818 822 818 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Zhao1">[12]</xref>
###xml 824 828 824 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Mammucari1">[40]</xref>
###xml 876 881 876 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 929 941 929 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Need4, Ube2h</italic>
###xml 955 965 955 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Acin, Amid</italic>
###xml 984 1005 984 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lysmd3, Becn1, Atg121</italic>
###xml 11 16 <span type="species:ncbi:9606">human</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 480 484 <span type="species:ncbi:10090">mice</span>
###xml 882 886 <span type="species:ncbi:10090">mice</span>
Animal and human studies have shown that caloric restriction enhances catabolic pathways in skeletal muscle through the activation of the energy sensor AMPK, which activates FoxO transcription factors leading to the up-regulation of MAFbx and MuRF1 [37]-[39]. Our results demonstrate that leptin increases the activity of AMPK in GAS of ob/ob mice as well as decreases the protein expression of FoxO3a and the mRNA and protein expression of MAFbx and MuRF1 in wild type and ob/ob mice. These data suggest that leptin treatment inhibits the catabolic pathway of proteins mediated by the AMPK. Overexpression of FoxO3a is sufficient to cause skeletal muscle atrophy by increasing the UPS activity [11], [14], but recent in vivo and in vitro studies have shown that FoxO3a also activates the autophagic/lysosomal pathway [12], [40]. In this sense, microarray data evidenced that ob/ob mice presented an upregulation of proteolytic (Need4, Ube2h), apoptotic (Acin, Amid), and autophagic (Lysmd3, Becn1, Atg121) genes, which were down-regulated by leptin treatment.
###end p 38
###begin p 39
###xml 177 181 177 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Stitt1">[16]</xref>
###xml 287 291 287 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Hu1">[17]</xref>
###xml 293 297 293 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Moylan1">[18]</xref>
###xml 351 355 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Rodrguez1">[41]</xref>
###xml 369 373 369 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Dube1">[42]</xref>
###xml 475 479 475 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Tajmir1">[43]</xref>
###xml 502 506 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Barazzoni1">[44]</xref>
###xml 638 642 638 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Tajmir1">[43]</xref>
###xml 644 648 644 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Barazzoni1">[44]</xref>
###xml 385 389 <span type="species:ncbi:10116">rats</span>
###xml 487 490 <span type="species:ncbi:10116">rat</span>
The activation of PI3K/Akt signaling by insulin and growth factors regulates muscular mass by reducing FoxO3a activity and, hence, by blocking the expression of MAFbx and MuRF1 [16]. Nonetheless, under certain conditions, regulation of Akt and FoxO seems to be independent of each other [17], [18]. Short-term leptin treatment activates Akt in smooth [41] and skeletal [42] muscles of rats, but long-term leptin treatment fails to activate this signaling pathway in myotubes [43] and in rat GAS muscle [44]. Our results showed that chronic leptin administration had no effect on Akt activity, which is in accordance with previous studies [43], [44].
###end p 39
###begin p 40
###xml 115 119 111 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Sandri2">[19]</xref>
###xml 258 262 250 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Sacheck1">[45]</xref>
###xml 368 372 356 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Lambert1">[46]</xref>
###xml 373 377 361 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Arany1">[48]</xref>
###xml 396 401 384 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 445 455 433 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pgc-1&#945;</italic>
###xml 519 523 503 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Kakuma1">[49]</xref>
###xml 754 759 730 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 831 841 807 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pgc-1&#945;</italic>
###xml 866 870 838 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Lee1">[50]</xref>
###xml 872 876 844 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Sriwijitkamol1">[51]</xref>
###xml 970 974 938 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Ojuka1">[52]</xref>
###xml 976 980 944 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Terada1">[53]</xref>
###xml 1234 1239 1198 1203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
###xml 361 367 <span type="species:ncbi:9606">humans</span>
###xml 402 406 <span type="species:ncbi:10090">mice</span>
###xml 760 764 <span type="species:ncbi:10090">mice</span>
###xml 1240 1244 <span type="species:ncbi:10090">mice</span>
PGC-1alpha protects skeletal muscle from atrophy by blocking FoxO3a action and atrophy-specific gene transcription [19]. The transcript levels of PGC-1alpha are dramatically decreased in models of mice with muscle atrophy induced by denervation and diabetes [45], while energy restriction enhances the expression of PGC-1alpha in skeletal muscle of rodents and humans [46]-[48]. Leptin-deficient ob/ob mice show a markedly reduced expression of Pgc-1alpha in brown adipose tissue, which is reverted by leptin treatment [49]. In the present study, we found that leptin deficiency is also associated with decreased PGC-1alpha expression in GAS muscle, and that leptin treatment significantly increased the PGC-1alpha protein in GAS muscle of wild type and ob/ob mice, which may be mediated by AMPK. In fact, AMPK reportedly enhances Pgc-1alpha up-regulation in muscle [50], [51] and AICAR, an AMPK-activating agent, leads to marked increases in PGC-1alpha protein content [52], [53]. Taken together, our findings suggest that leptin inhibits the pathways leading to muscle atrophy by increasing PGC-1alpha, which, in turn, decreases the expression of FoxO3a and its down-stream effectors, MAFbx and MuRF1 in GAS muscle of wild type and ob/ob mice.
###end p 40
###begin title 41
Leptin Enhances Muscle Growth
###end title 41
###begin p 42
###xml 218 222 218 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-OConnor1">[30]</xref>
###xml 421 425 421 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Adams1">[23]</xref>
###xml 661 665 661 665 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 665 669 665 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Rathbone1">[15]</xref>
###xml 671 675 671 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Li1">[54]</xref>
###xml 912 916 912 916 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 1029 1033 1029 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Park1">[55]</xref>
###xml 1047 1051 1047 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Lang1">[56]</xref>
###xml 1067 1071 1067 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Tajmir2">[57]</xref>
###xml 1102 1106 1102 1106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Oda1">[58]</xref>
###xml 1122 1126 1122 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Yu1">[59]</xref>
###xml 1218 1225 1218 1225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1261 1265 1261 1265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Harris1">[60]</xref>
###xml 1267 1271 1267 1271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Madiehe1">[61]</xref>
###xml 1303 1307 1303 1307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Harris1">[60]</xref>
###xml 1309 1313 1309 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Madiehe1">[61]</xref>
###xml 1390 1395 1390 1395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db/db</italic>
###xml 1458 1463 1458 1463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db/db</italic>
###xml 1396 1400 <span type="species:ncbi:10090">mice</span>
###xml 1464 1468 <span type="species:ncbi:10090">mice</span>
Muscle growth is related to a muscle fiber size increase, which involves a higher content of myofibrillar proteins as well as number of myonuclei to maintain a constant ratio between myonuclei per fiber and fiber size [30]. Mitogenic factors enhance cell cycle progression by increasing the activity of cyclin/CDK complexes, and inducing nuclear to cytoplasmic translocation of these inhibitors of cell cycle progression [23]. Moreover, FoxO proteins also regulate muscular mass by blocking the proliferation of muscle precursor cells via inhibiting DNA replication and cell cycle progression through the increase of the negative regulator of the cell cycle p27Kip1[15], [54]. In this regard, our data show for the first time that leptin enhances cell cycle progression in GAS muscle by increasing the activity of the positive regulators of the cell cycle cyclin D1 and PCNA, and by simultaneously decreasing p27Kip1. These findings are in accordance with the mitogenic effects described for leptin in vascular endothelial cells [55], hepatocytes [56] cardiomyocytes [57], vascular smooth muscle cells [58], and myoblasts [59]. Until now, there is little information available on the effect of leptin on muscle growth in vivo. The work published by Ruth Harris [60], [61] and by Abram M. Madiehe et al. [60], [61] points to an increased protein synthesis and muscle mass in some strains of db/db mice suggesting that leptin is able to increase the growth of db/db mice via a mechanism that is dependent on the short isoform of the leptin receptor.
###end p 42
###begin p 43
###xml 528 533 528 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 897 902 897 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 908 912 908 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-DellaFera1">[62]</xref>
###xml 914 918 914 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Pelleymounter1">[63]</xref>
###xml 982 987 982 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 534 538 <span type="species:ncbi:10090">mice</span>
###xml 599 603 <span type="species:ncbi:10090">mice</span>
###xml 903 907 <span type="species:ncbi:10090">mice</span>
###xml 988 992 <span type="species:ncbi:10090">mice</span>
In order to explore other potential hormonal effects, circulating concentrations of testosterone were assessed taking into account that androgenic hormones affect muscle mass. However, no significant differences were observed following leptin administration. These data seem to indicate that the leptin effects on muscle mass observed in the present study are not related to the changes in testosterone levels. Our findings do not rule out the possibility that other hormones may be involved in the regulation of muscle mass of ob/ob mice. It is possible that changes observed in the leptin-treated mice are related to the overall hormonal changes elicited by the administration of leptin rather than due to the direct effects of leptin on muscle mass. In addition, physical activity is a key regulator for muscle mass and leptin reportedly increases the reduced spontaneous locomotor activity of ob/ob mice [62], [63]. Therefore, the possibility that muscle mass in leptin-treated ob/ob mice may be affected by physical activity can not be ruled out. Unfortunately, physical activity was not assessed in the present study.
###end p 43
###begin p 44
###xml 145 149 145 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Feldman1">[64]</xref>
###xml 150 154 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Hittel1">[66]</xref>
###xml 289 293 289 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-McPherron1">[21]</xref>
###xml 295 299 295 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Lee2">[67]</xref>
###xml 407 411 407 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-ReiszPorszasz1">[68]</xref>
###xml 413 417 413 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Durieux1">[69]</xref>
###xml 588 592 588 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Taylor1">[70]</xref>
###xml 594 598 594 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-McCroskery1">[71]</xref>
###xml 619 623 619 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Langley1">[72]</xref>
###xml 625 629 625 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Joulia1">[73]</xref>
###xml 719 723 719 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Thomas1">[74]</xref>
###xml 799 803 799 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Yang1">[75]</xref>
###xml 805 809 805 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Ji1">[76]</xref>
###xml 890 895 890 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 1042 1047 1042 1047 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 1239 1244 1239 1244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 1270 1274 1270 1274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Allen1">[65]</xref>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
###xml 318 333 <span type="species:ncbi:10090">transgenic mice</span>
###xml 896 900 <span type="species:ncbi:10090">mice</span>
###xml 1048 1052 <span type="species:ncbi:10090">mice</span>
###xml 1245 1249 <span type="species:ncbi:10090">mice</span>
It has been suggested that myostatin plays a direct role in the deterioration of the skeletal muscle in states of obesity and insulin resistance [64]-[66]. The biological action of myostatin is well described in myostatin-deficient mice, which exhibit muscular hyperplasia and hypertrophy [21], [67]. On the contrary, transgenic mice over-expressing myostatin exhibit a reduced muscular mass and fiber size [68], [69], which has lead to consider myostatin as a negative regulator of skeletal muscle growth. Interestingly, myostatin regulates muscle growth by inhibiting the proliferation [70], [71] and differentiation [72], [73] of myoblasts. Myostatin inhibits the progression from the G1 to the S phase in myoblasts [74], blocks the expression of cyclin D1 and induces its degradation by the UPS [75], [76]. In this respect, a high protein expression of myostatin was observed in GAS of ob/ob mice in the present study. Importantly, our data show that leptin decreases the high myostatin protein expression related to leptin deficiency in ob/ob mice, suggesting that leptin enhances muscle growth. These data are consistent with the inhibitory effect of leptin on the high mRNA myostatin levels in adipose tissue and skeletal muscle of ob/ob mice previously observed [65].
###end p 44
###begin p 45
###xml 157 161 157 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Kamei1">[14]</xref>
###xml 247 251 247 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Liu1">[77]</xref>
###xml 253 257 253 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Allen2">[78]</xref>
###xml 432 436 432 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Taylor1">[70]</xref>
###xml 438 442 438 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Southgate1">[79]</xref>
###xml 443 447 443 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Amirouche1">[81]</xref>
###xml 722 726 722 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Booth1">[82]</xref>
###xml 727 731 727 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Clarke1">[84]</xref>
###xml 893 897 893 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Tintignac1">[85]</xref>
###xml 919 923 919 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Koncarevic1">[86]</xref>
###xml 973 977 973 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Kedar1">[87]</xref>
###xml 986 990 986 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Clarke1">[84]</xref>
###xml 1054 1058 1054 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Waddell1">[13]</xref>
###xml 1216 1221 1216 1221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 1259 1263 1259 1263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mhc1</italic>
###xml 1268 1273 1268 1273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mhc2a</italic>
###xml 1278 1286 1278 1286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">slow TnT</italic>
###xml 1302 1307 1302 1307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 1459 1464 1459 1464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 242 246 <span type="species:ncbi:10090">mice</span>
###xml 1222 1226 <span type="species:ncbi:10090">mice</span>
###xml 1308 1312 <span type="species:ncbi:10090">mice</span>
###xml 1465 1469 <span type="species:ncbi:10090">mice</span>
Fiber size augmentation requires an increase of the myofibrillar protein content. FoxO1 down-regulates genes implicated in muscle growth and differentiation [14], and myostatin expression has been shown to be induced by FoxO1 in myotubes and mice [77], [78]. Moreover, both myostatin and FoxO have been shown to inhibit protein synthesis by decreasing the activity of the components of the Akt/mammalian target of rapamycin pathway [70], [79]-[81]. An unexpected finding of our study was the discordance for mRNA and protein expression of myofibrillar MHC and TnT isoforms, which has been suggested to be due to a higher proteolytic rate or lower translational efficiency, rather than changes in the transcription process [82]-[84]. The proteins which are ubiquitinated by MAFbx, MuRF1 and Need4 remain largely unknown, but some evidence indicates that MAFbx ubiquitinates and degradates MyoD [85], Need4 targets Notch [86], and MuRF1 ubiquitinates and degrades Troponin I [87] and MHC [84], through a direct role of FoxO1 on the MuRF1 promoter activity [13]. Our data show that leptin administration prevented the increase of FoxO3a protein activity and MAFbx and MuRF1 gene and protein expression in wild type and ob/ob mice. Therefore, the increase of the Mhc1 and Mhc2a and slow TnT mRNA levels in ob/ob mice in the absence of an increase in their protein levels may represent a compensatory adaptation to increase levels of lost myofibrillar proteins in ob/ob mice.
###end p 45
###begin p 46
###xml 350 355 346 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 703 707 699 703 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 356 360 <span type="species:ncbi:10090">mice</span>
The control of muscle mass is regulated by a dynamic balance between the anabolic and catabolic processes. Data from our study indicate, for the first time, that leptin treatment prevents muscular atrophy by decreasing FoxO3a, MAFbx and MuRF1 protein expression in relation to an increase in the PGC-1alpha protein in the GAS muscle of wild type and ob/ob mice. The reduced skeletal muscle mass associated to leptin deficiency was prevented by leptin, on the one hand, reducing the negative regulator of muscle growth, myostatin, at the same time as by enhancing muscle cell proliferation through an increase in cyclin D1 and PCNA as well as the myofibrillar protein content of TnT, while decreasing p27Kip1.
###end p 46
###begin p 47
###xml 574 578 574 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Guerra1">[88]</xref>
###xml 100 106 <span type="species:ncbi:9606">humans</span>
###xml 175 183 <span type="species:ncbi:9606">patients</span>
###xml 337 343 <span type="species:ncbi:9606">humans</span>
###xml 424 429 <span type="species:ncbi:9606">women</span>
###xml 1361 1369 <span type="species:ncbi:9606">patients</span>
###xml 1425 1428 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1429 1437 <span type="species:ncbi:9606">patients</span>
Unfortunately, except in the rare cases of leptin deficiency, the clinical application of leptin in humans has not proved to be worthwhile in common obesity, since most obese patients exhibit hyperleptinemia pointing to the existence of leptin resistance. Therefore, no therapeutic benefit as regards improving body composition in obese humans might be foreseen. Furthermore, the sexual dimorphism relating to the fact that women have smaller muscles in spite of increased circulating leptin concentrations and higher leptin receptors expression should be also contemplated [88]. Nonetheless, practical applications of leptin administration may be envisaged in sports medicine and the area of disuse atrophy, which is a common clinical phenomenon. Prolonged immobilization due to fractures or neuromotor problems may represent scenarios for the application of leptin with therapeutic purposes targeting the restoration of muscle atrophy following limb disuse. Furthermore, from a physiologic perspective researchers involved in sports physiology might be also interested to gain more insight into the regulatory pathways involved in muscle mass accretion. Moreover, our study suggests that leptin treatment may be an attractive therapeutic approach to prevent muscular atrophy associated with catabolic diseases, which might be particularly useful in cachectic patients, such as frequently observed in oncological processes, HIV patients as well as other lipodystrophies.
###end p 47
###begin title 48
Materials and Methods
###end title 48
###begin title 49
Animals and Treatments
###end title 49
###begin p 50
###xml 70 75 70 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 275 280 267 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 624 629 616 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 915 925 907 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ad libitum</italic>
###xml 1453 1455 1445 1447 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 1478 1479 1470 1471 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
###xml 281 285 <span type="species:ncbi:10090">mice</span>
Ten-week-old male wild type (C57BL/6J) (n = 30) and genetically obese ob/ob mice (C57BL/6J) (n = 30) supplied by Harlan (Barcelona, Spain) were housed in a room with controlled temperature (22+/-2degreesC), and a 12:12 light-dark cycle (lights on at 08:00 am). Wild type and ob/ob mice were divided in control, leptin-treated (1 mg/kg/d) and pair-fed groups (n = 10 per group). A pilot study with different leptin doses and routes of administration was carried out in order to select the appropriate dose to ensure that its concentration would fell within the physiological range (nanomolar range) in both the wild type and ob/ob groups. The control and pair-fed groups received vehicle (PBS), while leptin-treated groups were intraperitoneally administered with leptin (Bachem, Bubendorf, Switzerland) twice a day at 08:00 and 20:00 for 28 days. Control and leptin-treated groups were provided with water and food ad libitum with a standard rodent chow (2014S Teklad, Harlan, Barcelona, Spain), while the daily food intake of the pair-fed groups was matched to the amount eaten by the leptin-treated groups the day before to discriminate the inhibitory effect of leptin on appetite. All experimental procedures conformed to the European Guidelines for the Care and Use of Laboratory Animals (directive 86/609) and were approved by the Ethical Committee for Animal Experimentation of the University of Navarra (080/05). Animals were sacrificed on the 28th day of treatment by CO2 inhalation 20 h after the last PBS or leptin administration (in order to avoid picking up effects reflecting an acute response) and after 8 h of fasting. Serum samples were obtained and stored at -80degreesC. Representative muscles of each muscle fiber type were excised: the SOL muscle is predominantly composed by oxidative, red fibers; the EDL contains mainly glycolytic, white fibers; while the GAS represents a mixed muscle type composed by both red and white fibers. Muscles of one leg were rapidly dissected out, weighed, frozen in liquid nitrogen, and stored at -80degreesC until mRNA and protein extraction, while the contralateral leg muscles were formalin-fixed for immunohistochemical analyses. Epididymal, perirrenal and subcutaneous adipose tissue depots were also excised.
###end p 50
###begin title 51
Blood Analysis
###end title 51
###begin p 52
###xml 472 476 472 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Wieland1">[89]</xref>
###xml 519 524 <span type="species:ncbi:10090">mouse</span>
Serum glucose concentrations were measured using a sensitive-automatic glucose sensor (Ascensia Elite, Bayer, Barcelona, Spain). Serum triglycerides were spectrophotometrically determined using a commercial kit (Infinity, Thermo Electron, Melbourne, Australia). Serum free fatty acid (FFA) concentrations were measured by a colorimetric determination using the NEFA C kit (WAKO Chemicals, Neuss, Germany). Serum glycerol concentrations were evaluated by enzymatic methods [89]. Insulin and leptin were determined using mouse ELISA kits (Crystal Chem Inc., Chicago, IL, USA). Adiponectin and testosterone concentrations were also assessed using ELISA kits (BioVendor Laboratory Medicine, Inc., Modrice, Czech Republic and R&D Systems Europe, Ltd., Abingdon, United Kingdom, respectively). Intra- and inter-assay coefficients of variation for measurements of insulin, leptin, adiponectin and testosterone were 2.6-4.2% for the former, and 5.3-8.1%, for the latter.
###end p 52
###begin title 53
Microarray Experiments and Analysis
###end title 53
###begin p 54
Total RNA was extracted from 20-30 mg of GAS muscle samples by homogenization with an ULTRA-TURRAX(R) T 25 basic (IKA(R) Werke GmbH, Staufen, Germany) using TRIzoltrade mark reagent (Invitrogen, Barcelona, Spain). Samples were purified using the RNeasy Mini kit (Qiagen, Barcelona, Spain) and treated with DNase I (RNase-free DNase Set, Qiagen) in order to remove any trace of genomic DNA.
###end p 54
###begin p 55
###xml 64 69 <span type="species:ncbi:10090">Mouse</span>
###xml 150 155 <span type="species:ncbi:10090">mouse</span>
Gene expression analyses were conducted using the Agilent Whole Mouse Genome array (G4121B, Agilent Technologies, Santa Clara, CA), containing 41,000 mouse genes and transcripts. Briefly, 1 microg of total RNA from each sample was amino-allyl labeled and amplified using the Amino Allyl MessageAmp II aRNA Amplification Kit (Ambion, Austin, TX, USA). Aliquots (1.2 microg) of amplified aRNA were fluorescently labeled using Cy3/Cy5 (Amersham, Biosciences, Buckinghamshire, UK) and then appropriately combined and hybridized to Agilent oligomicroarrays. Hybridizations were performed following a reference design, where control samples were pools of RNA from all individual samples. Two hybridizations with fluor reversal (Dye swap) were performed for each sample and 5 animals were used per group. After washing, microarray slides were scanned using a Gene Pix 4100A scanner (Axon Instruments, Union City, CA, USA) and image quantization was performed using the software GenePiX Pro 6.0. Gene expression data for all replicate experiments were analyzed using the GeneSpring GX software v 7.3.1 (Agilent Technologies). Clustering was accomplished with the Gene and Condition Tree algorithms. In addition, Gene Ontology groupings () and the KEGG website () were used in conjunction with GeneSpring () to identify pathways and functional groups of genes. All microarray data reported are described in accordance with MIAME guidelines. More information regarding the microarray experiments can be found at the EMBL-European Bioinformatics Institute (. ArrayExpress accession number: E-MEXP-1831).
###end p 55
###begin title 56
Real-Time PCR
###end title 56
###begin p 57
###xml 463 467 459 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Cataln1">[90]</xref>
###xml 688 696 684 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006808.s004">Table S4</xref>
###xml 1200 1203 1176 1179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18S</italic>
###xml 1304 1308 1272 1276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Cataln1">[90]</xref>
To validate the microarray data, a number of representative differentially expressed genes were selected to be individually studied by Real-Time PCR (n = 5-10 per group). For first strand cDNA synthesis, constant amounts of 1.5 microg of total RNA isolated from GAS muscle were reverse transcribed using random hexamers (Roche Molecular Biochemicals, Mannheim, Germany) as primers and 300 units of M-MLV reverse transcriptase (Invitrogen) as previously described [90]. The transcript levels were quantified by Real-Time PCR (7300 Real Time PCR System, Applied Biosystems, Foster City, CA, USA). Primers and probes were designed using the software Primer Express 2.0 (Applied Biosystems) (Table S4). Probes were designed to hybridize between exons to ensure the detection of the corresponding transcript avoiding genomic DNA amplification. The cDNA was amplified at the following conditions: 95degreesC for 10 min, followed by 45 cycles of 15 s at 95degreesC and 1 min at 59degreesC, using the TaqMan(R) Universal PCR Master Mix (Applied Biosystems). The primer and probe concentrations for gene amplification were 300 nmoL/L and 200 nmoL/L, respectively. All results were normalized to the levels of 18S rRNA (Applied Biosystems) and relative quantification was calculated using the DeltaDeltaCt formula [90]. Relative mRNA expression was expressed as fold expression over the calibrator sample (average of gene expression corresponding to the wild type group). All samples were run in triplicate and the average values were calculated.
###end p 57
###begin title 58
Western Blot
###end title 58
###begin p 59
###xml 124 125 124 125 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 294 295 285 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 394 398 379 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Bradford1">[91]</xref>
###xml 985 989 966 970 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 405 411 <span type="species:ncbi:9913">bovine</span>
###xml 858 863 <span type="species:ncbi:10090">mouse</span>
###xml 923 929 <span type="species:ncbi:9986">rabbit</span>
###xml 1014 1019 <span type="species:ncbi:10090">mouse</span>
###xml 1056 1060 <span type="species:ncbi:9925">goat</span>
###xml 1135 1141 <span type="species:ncbi:9986">rabbit</span>
###xml 1213 1219 <span type="species:ncbi:9986">rabbit</span>
###xml 1435 1446 <span type="species:ncbi:3704">horseradish</span>
###xml 1474 1478 <span type="species:ncbi:9925">goat</span>
###xml 1521 1527 <span type="species:ncbi:9986">rabbit</span>
###xml 1541 1546 <span type="species:ncbi:10090">mouse</span>
###xml 1589 1594 <span type="species:ncbi:10090">Mouse</span>
Muscle samples (20 mg) were homogenized in RIPA buffer (1 M Tris-HCl pH 7.4, 150 mM NaCl, 1% Triton X-100, 0.1% SDS, EDTA 2H2O 5 mM, 1% deoxycolate) supplemented with protease inhibitors (Completetrade mark Mini-EDTA free, Roche). Soluble proteins were recovered after centrifugation at 16,000 g for 15 min at 4degreesC. Protein concentration was determined according to the method of Bradford [91] using bovine serum albumine (BSA) (Sigma, St. Louis, MO, USA) as standard. Equal amounts of protein (30 microg) were boiled for 10 min and resolved on 10% SDS-PAGE at constant voltage (200 V for 1 h), except for MHC proteins (100 V for 4 h). Then, proteins were transferred to nitrocellulose membranes (BioRad, Hercules, CA, USA) and were blocked with 5% non-fat dry milk in TBS-Tween 20 0.05% for 1 h at room temperature (RT). Blots were then incubated with mouse monoclonal anti-PCNA (Dako Cytomation, Glostrup, Denmark), rabbit polyclonal anti-myostatin, anti-cyclin D1, and anti-p27Kip1 (Abcam, Cambridge, UK), mouse polyclonal anti-MHC I, anti-MHC II, goat polyclonal anti-PGC-1alpha, anti-slow TnT, anti-fast TnT, anti-MAFbx, and rabbit polyclonal anti-MuRF1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), rabbit polyclonal anti-Akt1/PKB (phospho Thr 308) and anti-Akt1/PKB (Upstate, Cambridge, UK) antibodies in blocking buffer overnight at 4degreesC. After washing with TBS-Tween 0.5% (5x5 min), membranes were incubated with horseradish peroxidase-conjugated anti-goat IgG (Zymed, San Francisco, CA, USA), anti-rabbit IgG, or anti-mouse IgG (Amersham Biosciences) for 1 h at RT. Mouse monoclonal anti-beta-actin (Sigma) was used for normalization of density values. The chemiluminescence ECL reactive (Enhanced Chemiluminescent System, Amersham Biosciences) was used to develop the bands, which were analyzed by densitometric analysis using the Gel Doc-Quantity One 4.5.0. software (Bio-Rad).
###end p 59
###begin title 60
Histological Analyses
###end title 60
###begin p 61
###xml 194 195 190 191 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 196 197 192 193 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 605 609 601 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 1379 1383 1369 1373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006808-Shu1">[92]</xref>
###xml 1971 1975 1961 1965 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kip1</sup>
###xml 504 510 <span type="species:ncbi:10090">murine</span>
###xml 514 518 <span type="species:ncbi:9925">goat</span>
###xml 922 927 <span type="species:ncbi:10090">mouse</span>
###xml 931 935 <span type="species:ncbi:9925">goat</span>
###xml 1072 1083 <span type="species:ncbi:3704">horseradish</span>
Sections (5 microm) of formalin-fixed paraffin-embedded muscles were dewaxed with xylene and hydrated in decreasing concentrations of ethanol. Endogen peroxidase activity was quenched using 3% H2O2 (Sigma) in absolute methanol for 20 min at RT, and washed 3 times with ethanol. Sections were immersed in 10 mM citrate buffer (pH 6.0) and heated using a microwave oven at 800 W for 10 min to enhance antigen retrieval. After cooling, sections were blocked for 30 min at RT in a humidified chamber with 5% murine or goat serum (Sigma) in TBS. Polyclonal antibodies against MAFbx, MuRF1, PCNA, cyclin D1, p27Kip1, fast TnT and slow TnT, used for immunohistochemistry were the same than those used for western blot studies. In addition, the dystrophin protein was also immunolocalized with a monoclonal antibody (Abcam). Sections were subsequently incubated with the appropriate dilutions of primary antibodies in TBS with 5% mouse or goat serum (Sigma) (1:50-100) in a humidified chamber overnight at 4degreesC. After washing with TBS (3x5 min), sections were incubated with horseradish peroxidase-conjugated secondary antibodies diluted in TBS with 5% BSA (1:100) for 1 h at RT. After washing with TBS (3x5 min), localization of the antigen-antibody binding antibodies was performed by adding diaminobenzidine (DAB) (Sigma) or DAB with glucose oxidase (Sigma) as developing system [92]. Negative control slides with omission of the primary antibodies were included in the immunostaining procedure. The reaction was stopped and contrasted with Harris hematoxylin solution (Sigma). Sections were dehydrated with increasing concentrations of ethanol and xylol, mounted in DePeX (Panreac, Barcelona, Spain), and observed with an optic microscope (Axiovert 40 CFL, Zeiss, Gottingen, Germany). Fiber size was determined by measuring the cross-sectional area of GAS, SOL and EDL muscle fibers with the Axiovision 4.6 program (Zeiss). Positive myonuclei for PCNA, cyclin D1 and p27kip1 in cross-sections of GAS muscles were quantified from 4 microscope fields (400X) randomly selected. Mean value was expressed as positive myonuclei number per 100 cells.
###end p 61
###begin title 62
Statistical Analysis
###end title 62
###begin p 63
###xml 306 307 304 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 644 645 642 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 840 841 838 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Data are expressed as mean+/-standard error of the mean (SEM). Global effects of genotype and treatment were determined using a two-way analysis of the variance (ANOVA). When interaction between both factors was detected, comparisons between groups were subsequently analyzed by Kruskal-Wallis followed by U-Mann Whitney tests. As previously outlined, Gene Ontology groupings were used to identify pathways significantly affected by leptin deficiency and administration. Furthermore, statistical comparisons for microarray data to identify differentially expressed genes across different groups were performed using one-way ANOVA and Student's t-tests as appropriate. All statistical analyses were performed by using the SPSS statistical program version 15.0 for Windows (SPSS, Chicago, IL, USA) and statistical significance was defined as P<0.05.
###end p 63
###begin title 64
Supporting Information
###end title 64
###begin p 65
###xml 51 55 <span type="species:ncbi:10090">Mice</span>
Biochemical Characteristics of Wild Type and ob/ob Mice
###end p 65
###begin p 66
(0.03 MB XLS)
###end p 66
###begin p 67
Click here for additional data file.
###end p 67
###begin p 68
###xml 60 64 <span type="species:ncbi:10090">Mice</span>
Genes Differentially Regulated by Leptin Treatment in ob/ob Mice
###end p 68
###begin p 69
(0.10 MB XLS)
###end p 69
###begin p 70
Click here for additional data file.
###end p 70
###begin p 71
###xml 88 92 <span type="species:ncbi:10090">Mice</span>
Genes Differentially Regulated by Leptin Treatment as Compared to Pair-Feeding in ob/ob Mice
###end p 71
###begin p 72
(0.38 MB XLS)
###end p 72
###begin p 73
Click here for additional data file.
###end p 73
###begin p 74
Sequences of the Primers and Taqman Probes Used in the Real-Time PCR
###end p 74
###begin p 75
(0.03 MB XLS)
###end p 75
###begin p 76
Click here for additional data file.
###end p 76
###begin p 77
###xml 69 74 69 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 177 182 177 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 250 255 250 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 292 297 292 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 350 355 350 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 374 379 374 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 552 557 552 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 612 617 612 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 654 659 654 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 900 905 900 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 75 79 <span type="species:ncbi:10090">Mice</span>
###xml 183 187 <span type="species:ncbi:10090">mice</span>
###xml 298 302 <span type="species:ncbi:10090">mice</span>
###xml 558 562 <span type="species:ncbi:10090">mice</span>
###xml 906 910 <span type="species:ncbi:10090">mice</span>
Leptin Treatment Decreases Body Weight and Body Fat in Wild Type and ob/ob Mice. (A) Body weight curves of PBS (open), pair-fed (gray) and leptin-treated (closed) wild type and ob/ob mice (n = 9-10 animals per group). **P<0.01 and ***P<0.001 for PBS ob/ob vs PBS wild type and leptin-treated ob/ob mice. +P<0.05, ++P<0.01 and +++P<0.001 for pair-fed ob/ob vs leptin-treated ob/ob. #P<0.05 and ##P<0.001 for PBS wild type vs leptin-treated wild type. (B) Daily food intake curves of PBS (open), pair-fed (gray) and leptin-treated (closed) wild type and ob/ob mice (n = 9-10 animals per group). ***P<0.001 for PBS ob/ob vs PBS wild type and leptin-treated ob/ob. #P<0.05 and # #P<0.001 for PBS wild type vs leptin-treated wild type. (C) Epididymal (EWAT), perirrenal (PWAT) and subcutaneous (SWAT) depots relative to body weight of PBS (open), pair-fed (gray) and leptin-treated (closed) wild type and ob/ob mice (9-10 animals per group). *P<0.05, **P<0.01 and ***P<0.001. Data are presented as mean+/-SEM. G: genotype, T: treatment. The striped line indicates the beginning of the pair-feeding treatment.
###end p 77
###begin p 78
(9.73 MB TIF)
###end p 78
###begin p 79
Click here for additional data file.
###end p 79
###begin p 80
###xml 97 102 97 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 122 127 122 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 396 401 396 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 128 132 <span type="species:ncbi:10090">Mice</span>
###xml 402 406 <span type="species:ncbi:10090">mice</span>
Hierarchical Clustering of the Gene Expression Profile of the Gastrocnemius Muscle of Wild Type, ob/ob and Leptin-Treated ob/ob Mice. Red represents up-regulated expression, green shows down-regulation, and yellow indicates a similar gene expression pattern as compared to reference. White boxes highlight that leptin treatment was able to reduce the mRNA expression of 732 up-regulated genes in ob/ob mice and to increase the expression of 846 down-regulated genes.
###end p 80
###begin p 81
(10.13 MB TIF)
###end p 81
###begin p 82
Click here for additional data file.
###end p 82
###begin p 83
###xml 336 341 328 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 555 560 547 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 851 856 843 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 342 346 <span type="species:ncbi:10090">mice</span>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
###xml 857 861 <span type="species:ncbi:10090">mice</span>
Analyses by Real-Time PCR of Key Genes Involved in Muscular Atrophy and Muscle Growth. (A) Real-Time PCR analysis of forkhead box class O3a (Foxo3a) and Foxo1, and peroxisome proliferator-activated receptor coactivator 1alpha (Pgc-1alpha) in gastrocnemius muscle of PBS (open), pair-fed (gray) and leptin-treated (closed) wild type and ob/ob mice (n = 5 per group). (B) Real-Time PCR analysis of muscle atrophy F box (MAFbx) and muscle RING finger 1 (MuRF1) in gastrocnemius muscle of PBS (open), pair-fed (gray) and leptin-treated (closed) wild type and ob/ob mice (n = 5 per group). (C) Real-Time PCR analysis of myosin heavy chain type I (Mhc1), myosin heavy chain type IIa (Mhc2a), myosin heavy chain type IIb (Mhc2b) and slow troponin T (slow TnT), in gastrocnemius muscle of PBS (open), pair-fed (gray) and leptin-treated (closed) wild type and ob/ob mice (n = 5 per group). Data are presented as mean+/-SEM of the ratio between gene expression and 18S rRNA. G: genotype, T: treatment.
###end p 83
###begin p 84
(0.39 MB TIF)
###end p 84
###begin p 85
Click here for additional data file.
###end p 85
###begin p 86
The authors would like to thank all the staff of the animal housing facilities for their technical expertise in animal care and handling and, in particular, to Javier Guillen and Juan Percaz.
###end p 86
###begin title 87
References
###end title 87
###begin article-title 88
Minireview: A hypothalamic role in energy balance with special emphasis on leptin.
###end article-title 88
###begin article-title 89
Leptin: a review of its peripheral actions and interactions.
###end article-title 89
###begin article-title 90
A heliocentric view of leptin.
###end article-title 90
###begin article-title 91
The response of skeletal muscle to leptin.
###end article-title 91
###begin article-title 92
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
Skeletal muscle accretion and turnover in lean and obese (ob/ob) mice.
###end article-title 92
###begin article-title 93
Skeletal muscle atrophy, a link between depression of protein synthesis and increase in degradation.
###end article-title 93
###begin article-title 94
Ubiquitin: structures, functions, mechanisms.
###end article-title 94
###begin article-title 95
Identification of ubiquitin ligases required for skeletal muscle atrophy.
###end article-title 95
###begin article-title 96
Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy.
###end article-title 96
###begin article-title 97
FoxOs at the crossroads of cellular metabolism, differentiation, and transformation.
###end article-title 97
###begin article-title 98
Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy.
###end article-title 98
###begin article-title 99
FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells.
###end article-title 99
###begin article-title 100
The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene.
###end article-title 100
###begin article-title 101
###xml 29 44 <span type="species:ncbi:10090">transgenic mice</span>
Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control.
###end article-title 101
###begin article-title 102
FoxO3a preferentially induces p27Kip1 expression while impairing muscle precursor cell-cycle progression.
###end article-title 102
###begin article-title 103
The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors.
###end article-title 103
###begin article-title 104
IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a.
###end article-title 104
###begin article-title 105
TNF induction of atrogin-1/MAFbx mRNA depends on Foxo4 expression but not AKT-Foxo1/3 signaling.
###end article-title 105
###begin article-title 106
PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription.
###end article-title 106
###begin article-title 107
###xml 56 60 <span type="species:ncbi:10090">mice</span>
Correction of obesity and diabetes in genetically obese mice by leptin gene therapy.
###end article-title 107
###begin article-title 108
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member.
###end article-title 108
###begin article-title 109
###xml 72 75 <span type="species:ncbi:10116">rat</span>
Satellite cell activity is required for hypertrophy of overloaded adult rat muscle.
###end article-title 109
###begin article-title 110
Satellite cell proliferation and skeletal muscle hypertrophy.
###end article-title 110
###begin article-title 111
###xml 68 71 <span type="species:ncbi:10116">rat</span>
Proliferating cell nuclear antigen (PCNA) is expressed in activated rat skeletal muscle satellite cells.
###end article-title 111
###begin article-title 112
Myogenic satellite cells: physiology to molecular biology.
###end article-title 112
###begin article-title 113
###xml 3 7 3 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
p27Kip1 metabolism: a fascinating labyrinth.
###end article-title 113
###begin article-title 114
Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation.
###end article-title 114
###begin article-title 115
Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization.
###end article-title 115
###begin article-title 116
###xml 86 93 86 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
Number and spatial distribution of nuclei in the muscle fibres of normal mice studied in vivo.
###end article-title 116
###begin article-title 117
Point:Counterpoint: Satellite cell addition is/is not obligatory for skeletal muscle hypertrophy.
###end article-title 117
###begin article-title 118
Protein metabolism. Slow and fast dietary proteins.
###end article-title 118
###begin article-title 119
###xml 73 77 <span type="species:ncbi:10090">mice</span>
Growth of adipose and lean tissue mass in hindlimbs of genetically obese mice during preobese and obese phases of development.
###end article-title 119
###begin article-title 120
###xml 115 120 115 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 122 127 <span type="species:ncbi:10090">mouse</span>
Functional and histological characteristics of skeletal muscle and the effects of leptin in the genetically obese (ob/ob) mouse.
###end article-title 120
###begin article-title 121
###xml 50 55 50 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
Increased protease activity in muscles of obese- (ob/ob) mice.
###end article-title 121
###begin article-title 122
Porcine leptin inhibits protein breakdown and stimulates fatty acid oxidation in C2C12 myotubes.
###end article-title 122
###begin article-title 123
###xml 74 77 <span type="species:ncbi:10116">rat</span>
Short-term effects of leptin on skeletal muscle protein metabolism in the rat.
###end article-title 123
###begin article-title 124
The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor.
###end article-title 124
###begin article-title 125
AMP-activated protein kinase agonists increase mRNA content of the muscle-specific ubiquitin ligases MAFbx and MuRF1 in C2C12 cells.
###end article-title 125
###begin article-title 126
AMPK activation stimulates myofibrillar protein degradation and expression of atrophy-related ubiquitin ligases by increasing FOXO transcription factors in C2C12 myotubes.
###end article-title 126
###begin article-title 127
###xml 44 51 44 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
FoxO3 controls autophagy in skeletal muscle in vivo.
###end article-title 127
###begin article-title 128
The inhibitory effect of leptin on angiotensin II-induced vasoconstriction in vascular smooth muscle cells is mediated via a nitric oxide-dependent mechanism.
###end article-title 128
###begin article-title 129
Leptin, skeletal muscle lipids, and lipid-induced insulin resistance.
###end article-title 129
###begin article-title 130
Acute and chronic leptin treatment mediate contrasting effects on signaling, glucose uptake, and GLUT4 translocation in L6-GLUT4myc myotubes.
###end article-title 130
###begin article-title 131
###xml 121 124 <span type="species:ncbi:10116">rat</span>
Moderate caloric restriction, but not physiological hyperleptinemia per se, enhances mitochondrial oxidative capacity in rat liver and skeletal muscle-tissue-specific impact on tissue triglyceride content and AKT activation.
###end article-title 131
###begin article-title 132
Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases.
###end article-title 132
###begin article-title 133
The effect of aging and caloric restriction on mitochondrial protein density and oxygen consumption.
###end article-title 133
###begin article-title 134
Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS.
###end article-title 134
###begin article-title 135
PGC-1 coactivators and skeletal muscle adaptations in health and disease.
###end article-title 135
###begin article-title 136
Role of leptin in peroxisome proliferator-activated receptor gamma coactivator-1 expression.
###end article-title 136
###begin article-title 137
AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1.
###end article-title 137
###begin article-title 138
###xml 66 70 <span type="species:ncbi:10116">rats</span>
LKB1-AMPK signaling in muscle from obese insulin-resistant Zucker rats and effects of training.
###end article-title 138
###begin article-title 139
###xml 10 12 10 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
Raising Ca2+ in L6 myotubes mimics effects of exercise on mitochondrial biogenesis in muscle.
###end article-title 139
###begin article-title 140
###xml 92 95 <span type="species:ncbi:10116">rat</span>
Effects of acute bouts of running and swimming exercise on PGC-1alpha protein expression in rat epitrochlearis and soleus muscle.
###end article-title 140
###begin article-title 141
Age-related differences in insulin-like growth factor-1 receptor signaling regulates Akt/FOXO3a and ERK/Fos pathways in vascular smooth muscle cells.
###end article-title 141
###begin article-title 142
###xml 132 139 132 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 144 152 144 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro.
###end article-title 142
###begin article-title 143
Leptin facilitates proliferation of hepatic stellate cells through up-regulation of platelet-derived growth factor receptor.
###end article-title 143
###begin article-title 144
Leptin increases cardiomyocyte hyperplasia via extracellular signal-regulated kinase- and phosphatidylinositol 3-kinase-dependent signaling pathways.
###end article-title 144
###begin article-title 145
###xml 18 21 <span type="species:ncbi:10116">rat</span>
Leptin stimulates rat aortic smooth muscle cell proliferation and migration.
###end article-title 145
###begin article-title 146
Leptin promotes proliferation and inhibits differentiation in porcine skeletal myoblasts.
###end article-title 146
###begin article-title 147
###xml 19 24 19 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db/db</italic>
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 38 40 38 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db</italic>
###xml 41 42 41 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 43 47 <span type="species:ncbi:10090">mice</span>
Parabiosis between db/db and ob/ob or db/+ mice.
###end article-title 147
###begin article-title 148
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db/db</italic>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Strain-dependent stimulation of growth in leptin-treated obese db/db mice.
###end article-title 148
###begin article-title 149
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 21 25 <span type="species:ncbi:10090">mice</span>
Sensitivity of ob/ob mice to leptin-induced adipose tissue apoptosis.
###end article-title 149
###begin article-title 150
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Effects of the obese gene product on body weight regulation in ob/ob mice.
###end article-title 150
###begin article-title 151
Myostatin modulates adipogenesis to generate adipocytes with favorable metabolic effects.
###end article-title 151
###begin article-title 152
###xml 131 135 <span type="species:ncbi:10090">mice</span>
Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice.
###end article-title 152
###begin article-title 153
###xml 88 93 <span type="species:ncbi:9606">women</span>
Increased secretion and expression of myostatin in skeletal muscle from extremely obese women.
###end article-title 153
###begin article-title 154
Regulation of myostatin activity and muscle growth.
###end article-title 154
###begin article-title 155
###xml 35 50 <span type="species:ncbi:10090">transgenic mice</span>
Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin.
###end article-title 155
###begin article-title 156
Ectopic expression of myostatin induces atrophy of adult skeletal muscle by decreasing muscle gene expression.
###end article-title 156
###begin article-title 157
Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells.
###end article-title 157
###begin article-title 158
Myostatin negatively regulates satellite cell activation and self-renewal.
###end article-title 158
###begin article-title 159
Myostatin inhibits myoblast differentiation by down-regulating MyoD expression.
###end article-title 159
###begin article-title 160
Mechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin.
###end article-title 160
###begin article-title 161
Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation.
###end article-title 161
###begin article-title 162
Myostatin induces cyclin D1 degradation to cause cell cycle arrest through a phosphatidylinositol 3-kinase/AKT/GSK-3beta pathway and is antagonized by insulin-like growth factor 1.
###end article-title 162
###begin article-title 163
Myostatin induces p300 degradation to silence cyclin D1 expression through the PI3K/PTEN/Akt pathway.
###end article-title 163
###begin article-title 164
###xml 94 98 <span type="species:ncbi:10090">mice</span>
Effect of RNA oligonucleotide targeting Foxo-1 on muscle growth in normal and cancer cachexia mice.
###end article-title 164
###begin article-title 165
Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors.
###end article-title 165
###begin article-title 166
FOXO1 regulates the expression of 4E-BP1 and inhibits mTOR signaling in mammalian skeletal muscle.
###end article-title 166
###begin article-title 167
Forkhead box protein O1 negatively regulates skeletal myocyte differentiation through degradation of mammalian target of rapamycin pathway components.
###end article-title 167
###begin article-title 168
Down-regulation of Akt/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle.
###end article-title 168
###begin article-title 169
Changes in skeletal muscle gene expression consequent to altered weight bearing.
###end article-title 169
###begin article-title 170
###xml 123 126 <span type="species:ncbi:10116">rat</span>
Protein and mRNA levels of the myosin heavy chain isoforms Ibeta, IIa, IIx and IIb in type I and type II fibre-predominant rat skeletal muscles in response to chronic alcohol feeding.
###end article-title 170
###begin article-title 171
The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle.
###end article-title 171
###begin article-title 172
Degradation of MyoD mediated by the SCF (MAFbx) ubiquitin ligase.
###end article-title 172
###begin article-title 173
The ubiquitin-protein ligase Nedd4 targets Notch1 in skeletal muscle and distinguishes the subset of atrophies caused by reduced muscle tension.
###end article-title 173
###begin article-title 174
Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I. Proc Natl Acad Sci USA
###end article-title 174
###begin article-title 175
Gender dimorphism in skeletal muscle leptin receptors, serum leptin and insulin sensitivity.
###end article-title 175
###begin article-title 176
Enzymic method for the determination of glycerin.
###end article-title 176
###begin article-title 177
###xml 42 47 <span type="species:ncbi:9606">human</span>
Validation of endogenous control genes in human adipose tissue: relevance to obesity and obesity-associated type 2 diabetes mellitus.
###end article-title 177
###begin article-title 178
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
###end article-title 178
###begin article-title 179
The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system.
###end article-title 179
###begin p 180
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 180
###begin p 181
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: NS was recipient of a fellowship for specialist training from the Department of Industry of the Gobierno de Navarra of Spain. This work was supported by grants from the Fundacion Mutua Madrilena to GF; from the Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria (FIS) del Ministerio de Sanidad y Consumo to GF and JG-A; and from the Department of Health of the Gobierno de Navarra of Spain to GF and JG-A CIBER de Fisiopatologia de la Obesidad y Nutricion (CIBEROBN) is an initiative of the Instituto de Salud Carlos III, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 181

